Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

The transcription factor orthodenticle homeobox 2 influences axonal projections and vulnerability of midbrain dopaminergic neurons.

Chung CY, Licznerski P, Alavian KN, Simeone A, Lin Z, Martin E, Vance J, Isacson O.

Brain. 2010 Jul;133(Pt 7):2022-31. doi: 10.1093/brain/awq142. Epub 2010 Jun 23.

2.

The role of otx2 in adult mesencephalic-diencephalic dopaminergic neurons.

Simeone A, Di Salvio M, Di Giovannantonio LG, Acampora D, Omodei D, Tomasetti C.

Mol Neurobiol. 2011 Apr;43(2):107-13. doi: 10.1007/s12035-010-8148-y. Epub 2010 Nov 18. Review.

PMID:
21086067
3.
4.

Diversity matters - heterogeneity of dopaminergic neurons in the ventral mesencephalon and its relation to Parkinson's Disease.

Vogt Weisenhorn DM, Giesert F, Wurst W.

J Neurochem. 2016 Oct;139 Suppl 1:8-26. doi: 10.1111/jnc.13670. Epub 2016 Jun 27. Review.

5.

Cholinergic modulation of midbrain dopaminergic systems.

Mena-Segovia J, Winn P, Bolam JP.

Brain Res Rev. 2008 Aug;58(2):265-71. doi: 10.1016/j.brainresrev.2008.02.003. Epub 2008 Feb 21. Review.

PMID:
18343506
6.

Biochemistry of Parkinson's disease with special reference to the dopaminergic systems.

Hirsch EC.

Mol Neurobiol. 1994 Aug-Dec;9(1-3):135-42. Review.

PMID:
7888089
7.
8.

Molecular determinants of selective dopaminergic vulnerability in Parkinson's disease: an update.

Brichta L, Greengard P.

Front Neuroanat. 2014 Dec 15;8:152. doi: 10.3389/fnana.2014.00152. eCollection 2014. Review.

9.

The role of Otx genes in progenitor domains of ventral midbrain.

Simeone A, Puelles E, Acampora D, Omodei D, Mancuso P, Giovanni Di Giovannantonio L.

Adv Exp Med Biol. 2009;651:36-46. Review.

PMID:
19731548
10.

An update on the connections of the ventral mesencephalic dopaminergic complex.

Yetnikoff L, Lavezzi HN, Reichard RA, Zahm DS.

Neuroscience. 2014 Dec 12;282:23-48. doi: 10.1016/j.neuroscience.2014.04.010. Epub 2014 Apr 13. Review.

11.

Development and function of the midbrain dopamine system: what we know and what we need to.

Bissonette GB, Roesch MR.

Genes Brain Behav. 2016 Jan;15(1):62-73. doi: 10.1111/gbb.12257. Epub 2015 Nov 8. Review.

12.

Molecular Programming of Mesodiencephalic Dopaminergic Neuronal Subsets.

Smidt MP.

Front Neuroanat. 2017 Jul 19;11:59. doi: 10.3389/fnana.2017.00059. eCollection 2017. Review.

13.

The role of dopaminergic and serotonergic systems in neurodevelopmental disorders: a focus on epilepsy and seizure susceptibility.

Tripathi PP, Bozzi Y.

Bioimpacts. 2015;5(2):97-102. doi: 10.15171/bi.2015.07. Epub 2015 Apr 6. Review.

14.

Opioid and hypocretin neuromodulation of VTA neuronal subpopulations.

Thomas TS, Baimel C, Borgland SL.

Br J Pharmacol. 2017 Aug 28. doi: 10.1111/bph.13993. [Epub ahead of print] Review.

PMID:
28849596

Supplemental Content

Support Center